Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study
- PMID: 34194493
- PMCID: PMC8203403
- DOI: 10.1155/2021/6685469
Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study
Abstract
Primary aldosteronism (PA) is one of the most common forms of secondary hypertension. Recent studies suggest that, compared with essential hypertension (EH), PA presents more severe disorders of glycolipid metabolism and organ damages. This case-control retrospective study aimed to ascertain clinical features and metabolic parameters between Chinese patients of PA and EH. 174 PA patients and 174 matched EH patients were recruited. Their clinical features, biochemistry parameters, the ventricular septal thickness, and left ventricular mass index (LVMI) were compared. HOMA-β% and HOMA-IR were calculated to evaluate glucose metabolism. The results showed that there was no significant difference regarding BMI, waist-to-hip ratio, and blood pressure between the two groups. The blood potassium level was significantly lower in PA patients than those in EH patients. The abnormal glucose tolerance and the incidence of diabetes in the PA group were not significantly different from those in EH group, but the insulin secretion levels at 0 min and 30 min were significantly weaker than those in the EH group, and the HOMA-β% was also lower in the PA group than those in the EH group. Left ventricular structural abnormalities in PA patients were more severe than those in EH patients. Subtype analysis indicated that patient with aldosterone-producing adenoma (APA) has more serious hypokalemia and lower levels of HOMA-β% and HOMA-IR comparing to those in the idiopathic adrenal hyperplasia (IHA) patient. These findings demonstrated that PA patients showed more impaired insulin secretion function and more severe left ventricular structural damage compared with EH patients.
Copyright © 2021 Xiaoyu Huang et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures

Similar articles
-
[Comparison on metabolic disorders and uric acid levels between patients with primary aldosteronism and essential hypertension].Zhonghua Xin Xue Guan Bing Za Zhi. 2016 Sep 24;44(9):743-749. doi: 10.3760/cma.j.issn.0253-3758.2016.09.003. Zhonghua Xin Xue Guan Bing Za Zhi. 2016. PMID: 27667270 Chinese.
-
Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism.Front Endocrinol (Lausanne). 2020 Sep 25;11:547356. doi: 10.3389/fendo.2020.547356. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33101195 Free PMC article.
-
A possible association between primary aldosteronism and a lower beta-cell function.J Hypertens. 2007 Oct;25(10):2125-30. doi: 10.1097/HJH.0b013e3282861fa4. J Hypertens. 2007. PMID: 17885557
-
Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis.Front Endocrinol (Lausanne). 2022 Mar 31;13:870047. doi: 10.3389/fendo.2022.870047. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432215 Free PMC article.
-
Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis.Ir J Med Sci. 2014 Jun;183(2):283-91. doi: 10.1007/s11845-013-1007-x. Epub 2013 Aug 30. Ir J Med Sci. 2014. PMID: 23990176 Review.
Cited by
-
Glucocorticoids: The culprit behind metabolic disorders in primary Aldosteronism? A narrative review.J Clin Transl Endocrinol. 2025 May 28;41:100401. doi: 10.1016/j.jcte.2025.100401. eCollection 2025 Sep. J Clin Transl Endocrinol. 2025. PMID: 40519520 Free PMC article. Review.
-
Development and Implementation of a Dynamically Updated Big Data Intelligence Platform Using Electronic Medical Records for Secondary Hypertension.Rev Cardiovasc Med. 2024 Mar 12;25(3):104. doi: 10.31083/j.rcm2503104. eCollection 2024 Mar. Rev Cardiovasc Med. 2024. PMID: 39076957 Free PMC article.
-
Meta-analysis of blood parameters related to lipid and glucose metabolism between two subtypes of primary aldosteronism.J Clin Hypertens (Greenwich). 2023 Jan;25(1):13-21. doi: 10.1111/jch.14607. Epub 2022 Dec 9. J Clin Hypertens (Greenwich). 2023. PMID: 36484331 Free PMC article.
-
Safety and efficacy of bilateral superselective adrenal arterial embolization for treatment of idiopathic hyperaldosteronism: a prospective single-center study.BMC Surg. 2024 Aug 24;24(1):242. doi: 10.1186/s12893-024-02530-z. BMC Surg. 2024. PMID: 39182043 Free PMC article.
-
The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.BMC Endocr Disord. 2022 Aug 31;22(1):217. doi: 10.1186/s12902-022-01135-y. BMC Endocr Disord. 2022. PMID: 36045354 Free PMC article.
References
-
- Wang Z., Chen Z., Zhang L., et al. Status of hypertension in China: results from the China hypertension survey, 2012–2015. Circulation. 137(22):2344–2356. - PubMed
-
- Sang X., Jiang Y., Wang W., et al. Prevalence of and risk factors for primary aldosteronism among patients with resistant hypertension in China. Journal of Hypertension. 31(7):1465–1471. - PubMed
-
- Funder J. W., Carey R. M., Mantero F., et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 101(5):1889–1916. - PubMed
-
- Xu Z., Yang J., Hu J., et al. Primary aldosteronism in patients in China with recently detected hypertension. Journal of the American College of Cardiology. 75(16):1913–1922. - PubMed
LinkOut - more resources
Full Text Sources